BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30554192)

  • 1. Integrated Analysis of the Endoscopic, Pathological and Molecular Characteristics of Colorectal Tumorigenesis.
    Suzuki H; Yamamoto E; Yamano HO; Nakase H; Sugai T
    Digestion; 2019; 99(1):33-38. PubMed ID: 30554192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.
    Aoki H; Yamamoto E; Yamano HO; Sugai T; Kimura T; Tanaka Y; Matsushita HO; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Harada T; Sudo G; Eizuka M; Yorozu A; Kitajima H; Niinuma T; Kai M; Nojima M; Suzuki H; Nakase H
    Dig Dis Sci; 2018 Jul; 63(7):1920-1928. PubMed ID: 29546645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic and molecular characterization of colorectal sessile serrated adenoma/polyps with cytologic dysplasia.
    Tanaka Y; Yamano HO; Yamamoto E; Matushita HO; Aoki H; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Eizuka M; Sugai T; Suzuki H; Nakase H
    Gastrointest Endosc; 2017 Dec; 86(6):1131-1138.e4. PubMed ID: 28501592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic diagnosis of sessile serrated adenoma/polyp with and without dysplasia/carcinoma.
    Murakami T; Sakamoto N; Nagahara A
    World J Gastroenterol; 2018 Aug; 24(29):3250-3259. PubMed ID: 30090005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
    Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of
    Aoki H; Yamamoto E; Takasawa A; Niinuma T; Yamano HO; Harada T; Matsushita HO; Yoshikawa K; Takagi R; Harada E; Tanaka Y; Yoshida Y; Aoyama T; Eizuka M; Yorozu A; Kitajima H; Kai M; Sawada N; Sugai T; Nakase H; Suzuki H
    Oncotarget; 2018 Jan; 9(4):4707-4721. PubMed ID: 29435136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of SMOC1 is associated with progression of colorectal traditional serrated adenomas.
    Aoki H; Takasawa A; Yamamoto E; Niinuma T; Yamano HO; Harada T; Kubo T; Yorozu A; Kitajima H; Ishiguro K; Kai M; Katanuma A; Shinohara T; Nakase H; Sugai T; Osanai M; Suzuki H
    BMC Gastroenterol; 2024 Mar; 24(1):91. PubMed ID: 38429655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
    Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
    Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma.
    Kimura T; Yamamoto E; Yamano HO; Suzuki H; Kamimae S; Nojima M; Sawada T; Ashida M; Yoshikawa K; Takagi R; Kato R; Harada T; Suzuki R; Maruyama R; Kai M; Imai K; Shinomura Y; Sugai T; Toyota M
    Am J Gastroenterol; 2012 Mar; 107(3):460-9. PubMed ID: 22233696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serrated pathway in colorectal carcinogenesis.
    Yamane L; Scapulatempo-Neto C; Reis RM; Guimarães DP
    World J Gastroenterol; 2014 Mar; 20(10):2634-40. PubMed ID: 24627599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
    Kim YH; Kakar S; Cun L; Deng G; Kim YS
    Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions.
    Tsai JH; Cheng CH; Chen CC; Lin YL; Lin LI; Chen ML; Liau JY
    Histopathology; 2016 May; 68(6):810-8. PubMed ID: 26496853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
    Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
    Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
    Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
    Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serrated adenoma of the colorectum and the DNA-methylator phenotype.
    Jass JR
    Nat Clin Pract Oncol; 2005 Aug; 2(8):398-405. PubMed ID: 16130936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal serrated adenocarcinoma.
    Mäkinen MJ
    Histopathology; 2007 Jan; 50(1):131-50. PubMed ID: 17204027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF inhibitor treatment of melanoma causing colonic polyps: An alternative hypothesis.
    Kelleher FC; Callaghan G; Gallagher C; O'Sullivan H
    World J Gastroenterol; 2017 May; 23(17):3022-3029. PubMed ID: 28533659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.